Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Abstracts of the meeting of the Belgian Society of Internal Medicine (27 February 1988)

Autor: L. Siemons, M. L. Hautekeete, M. Pcctcrmans, S. Pattyn, R. De Bock, H.De Mey

Publikováno v: Acta clinica Belgica. 43(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52edc62d5dece45cdaa6a5bcab94aeba
https://pubmed.ncbi.nlm.nih.gov/27191658

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy

Autor: M. Vandenbergh, M. Vandercam, Winfried V. Kern, Françoise Crokaert, Marianne Paesmans, Jean Klastersky, Stephen H. Zinner, Dan Engelhard, A. Cometta, A. Padmos, Thierry Calandra, Volkan Korten, M. P. Glauser, R. De Bock, A. Skoutelis, C. Viscoli, Oscar Marchetti, Hamdi Akan, H. Gaya

Publikováno v: Clinical Infectious Diseases, vol. 37, no. 3, pp. 382-9

This prospective, double-blind trial assessed whether the addition of a glycopeptide would be able to reduce the time to defervescence in neutropenic patients with cancer who had persistent fever 48-60 h after the initiation of empirical piperacillin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a048eb5e912a457d7dbd75522ac007fc
https://doi.org/10.1086/376637

Zobrazit plný text záznamu

Molecular cytogenetic analysis of 10;11 rearrangements in acute myeloid leukemia

Autor: R De Bock, Ann Janssens, A. De Paepe, Franki Speleman, H Van Limbergen, Bruce Poppe, L Noens

Publikováno v: Leukemia. 16:344-351

MLLT10 (previously called AF10) is a moderately common MLL fusion partner predominantly occurring in acute monoblastic leukemia (AML-M5). 10;11 rearrangements require at least three breaks in order to generate an in-frame MLL-MLLT10 fusion as a resul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aeb32f13c1d320c3ba4f1a272bfec69
https://doi.org/10.1038/sj.leu.2402397

Zobrazit plný text záznamu

Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group

Autor: A. Van Hoof, J. Thomas, Patrice Carde, Riet Somers, J.H. Meerwaldt, M. van Glabbeke, C De Wolf-Peeters, R. De Bock, Anton Hagenbeek, J M Raemaekers

Publikováno v: Journal of Clinical Oncology. 16:41-47

PURPOSE Interferon alfa has shown significant activity in patients with low-grade malignant non-Hodgkin's lymphoma (NHL). In 1985, we initiated a prospective randomized study in which the potential benefit of interferon alfa given as maintenance trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::007f3a98d1579474c0bd5d524fdee96f
https://doi.org/10.1200/jco.1998.16.1.41

Zobrazit plný text záznamu

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program

Autor: I Langenaeken, Thierry Calandra, M. P. Glauser, A Padmos, Marianne Paesmans, A Del Favero, Stephen H. Zinner, F Crokaert, R. De Bock, Jean Klastersky, W V Kern, H Gaya, C Viscoli, G Bucaneve, A Micozzi, A. Cometta

Publikováno v: Europe PubMed Central

Combinations of beta-lactams plus aminoglycosides have been standard therapy for suspected infections in granulocytopenic cancer patients, especially those with profound long-lasting granulocytopenia. With the advent of new broad-spectrum bactericida

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a930ec5530525c1989137890e410003
https://doi.org/10.1128/aac.40.5.1108

Zobrazit plný text záznamu

EORTC study of non-Hodgkin's lymphoma: Phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma

Autor: D Bron, J. Thomas, Umberto Tirelli, Riet Somers, Nicole Duez, C De Wolf-Peeters, J. J. Keunig, Patrice Carde, M. van Glabbeke, Alain Delmer, R. De bock

Publikováno v: Europe PubMed Central

Summary In the EORTC lymphoma cooperative group, a randomized phase HI study was done for patients with stage II, III, IV intermediate- and high-grade lymphoma. Eight courses of CHVmP-VB were compared to eight courses of ProMACE-MOPP. Response was ev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7cde098092a37ea7a01fa0e94cbebc7
https://doi.org/10.1093/annonc/5.suppl_2.s85

Zobrazit plný text záznamu

Nevrite Optique dans le lymphome non Hodgkinien

Autor: I. Neetens, A. Clemens, P. van den Ende, Adolphe Neetens, R. De Bock

Publikováno v: Klinische Monatsblätter für Augenheilkunde. 200:525-528

Optic neuropathy during non-Hodgkin lymphoma is a late central nervous system complication of unfavourable prognosis. It appears especially with involvement of the bone marrow. A normal cerebrospinal fluid, lack of any beneficial effect of the chemo-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e60a6f740c0782933f19de311c5354a6
https://doi.org/10.1055/s-2008-1045815

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání